caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871534883

Marshall KimM.D., PH.D.

PRACTICEGLAUCOMA CENTER OF HAWAII, LLCSee all providers at this practice →
OphthalmologyHonolulu, HII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Marshall Kim's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Diagnostic Laboratory Services, Inc
Clinical Laboratory · Aiea, HI
54153
Clinical Laboratories Of Hawaii Llp
Clinical Laboratory · Ewa Beach, HI
23133
THE QUEEN'S MEDICAL CENTER1840
Youngkyo Kim
Internal Medicine · Honolulu, HI
1644
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,263
Unique beneficiaries
—
Total services
1,708
Distinct HCPCS
10
Medicare payment
$76K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 103 Ophthalmology providers in HI — above median (cohort median 1,487).
PRESCRIBING · PART D · 2024
Total Rx claims
2,800
Beneficiaries
—
Total drug cost
$347K
Distinct drugs
22
Brand share
32.6%
Top prescribed drugs
Latanoprost1,218 claims
Ciprofloxacin Hcl290 claims
Dorzolamide Hcl/Timolol Maleat233 claims
Brimonidine Tartrate155 claims
Neomycin/Polymyxin B/Dexametha103 claims
QUALITY · MIPS · 2024
Final MIPS score
97.0
Quality
89.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.93%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$86
Payment records
4
By payment type
Food and Beverage$86